Sign in
4

Changes in Ownership

Aligos Therapeutics, Inc. Filed Acc 0001610717-24-000503

Options or other derivatives

  • Chief Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Achneck Hardean · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-10-08 Grant or award : show line 1 in the form Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/form4.xml…